Once the CD8+ T cells get activated following recognition of tumour‐specific antigens on the APC surface, they home into the tumour microenvironment, recognize the tumour antigens on the live tumour cells and post‐tumour antigen engagement, they secrete perforins and kill those tumour cells (Sagnella et al., 2020). The gene discussed is PRF1; the disease is neoplasm.